Table 4 Concerns about genomic science and technology
Concerns | Unconcerned (%) | Somewhat unconcerned (%) | Somewhat concerned (%) | Very concerned (%) | Mean (SD) |
|---|---|---|---|---|---|
Clinical usefulness of genetic data (specificity/sensitivity/reliability | 3.2 | 9.7 | 45.2 | 41.9 | 3.26 (0.78) |
Extra effort without changing treatment | 0 | 12.9 | 48.4 | 38.7 | 3.26 (0.68) |
Decision-making on what results to return to patients | 3.2 | 13 | 54.8 | 29 | 3.1 (0.75) |
Results leading to ineffective or harmful treatment | 3.2 | 22.6 | 42 | 32.2 | 3.03 (0.84) |
Cost | 0 | 3.2 | 35.5 | 61.3 | 3.58 (0.56) |
Immaturity of genomic science and technologies | 3.2 | 19.3 | 42 | 35.5 | 3.1 (0.83) |
Patient comprehension of genomic science and technologies | 0 | 9.7 | 42 | 48.3 | 3.39 (0.67) |
Unexpected germline findings | 6.4 | 42 | 42 | 9.6 | 2.55 (0.77) |